The SynthID Bio watermark tags AI-designed proteins and matched unwatermarked binders in wet-lab tests on three targets, ...

Google DeepMind’s SynthID Bio hides a signature in AI-designed proteins, and the marked binders matched unmarked ones in lab ...

Google DeepMind unveiled SynthID Bio on September 30, 2026, a family of watermarking methods that embeds an imperceptible, ...

The model can be accessed through Latent's web-based platform for push-button protein design. Sign ups are open now for early access: platform.latentlabs.com Extensive lab validation shows picomolar ...

Since its release in 2024, the open-source platform BindCraft, developed at EPFL, has already disrupted the world of protein design. Physical interactions between proteins influence anything from cell ...

For the field of drug development, hitting the right target with atomic precision to achieve therapeutic effect remains the core challenge. While traditional R&D pipelines are dependent on ...

A vision of the future of protein engineering The new approach allows the identification of near-optimal binder templates from the human proteome, facilitating the humanization of designed therapies, ...

BOSTON--(BUSINESS WIRE)--Manifold Bio, a platform therapeutics company pioneering direct-to-vivo drug discovery, today announced a joint study with NVIDIA to validate Proteina-Complexa, NVIDIA's ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics, Inc., a genetic technologies company applying AI to empower patients everywhere with genetic agency, today announced the launch of Dyno Psi-Phi ...

Physical interactions between proteins influence anything from cell signaling and growth to immune responses, so the ability to control these interactions is of great interest to biologists.

CAR T cell therapy, which involves genetically modifying a patient’s own immune cells to fight their cancer, is a technique that has shown great promise, especially against blood cancers. But ...